Atrish Bagchi
Impact in
-
- HER2/EGFR in Cancer Research
- Cancer Immunotherapy and Biomarkers
-
- Monoclonal and Polyclonal Antibodies Research
Papers in
- Oncology 7
- HER2/EGFR in Cancer Research 6
- CAR-T cell therapy research 1
-
- Monoclonal and Polyclonal Antibodies Research 2
- Co-authors
- Kathryn M. Ferguson (5 shared papers)Karl R. Schmitz (2 shared papers)Rob C. Roovers (2 shared papers)Paul M.P. van Bergen en Henegouwen (2 shared papers)Mark A. Lemmon (3 shared papers)Nicholas J. Bessman (2 shared papers)Amélie Forest (1 shared paper)Scott W. Eastman (1 shared paper)
- Journals
- Structure (2 papers)Biophysical Journal (1 paper)Molecular Cancer Therapeutics (1 paper)Biochemical and Biophysical Research Communications (1 paper)Cell Reports (1 paper)
- Partner nations
- United StatesNetherlandsUnited Kingdom
In The Last Decade
Atrish Bagchi
7 papers receiving 350 citations
Peers
Comparison fields: 5 of 37
- Oncology 115
- Radiology, Nuclear Medicine and Imaging 109
- Biomaterials 22
- Molecular Biology 106
- Pulmonary and Respiratory Medicine 37
Countries citing papers authored by Atrish Bagchi
This map shows the geographic impact of Atrish Bagchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Atrish Bagchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Atrish Bagchi more than expected).
Fields of papers citing papers by Atrish Bagchi
This network shows the impact of papers produced by Atrish Bagchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Atrish Bagchi. The network helps show where Atrish Bagchi may publish in the future.
Co-authors
The 25 scholars most cited alongside Atrish Bagchi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 209 | |
| 2 | 2014 | 78 | |
| 3 | 2017 | 51 | |
| 4 | 2015 | 13 | |
| 5 | 2023 | 7 | |
| 6 | 2024 | 4 | |
| 7 | 2014 | 1 |
About Atrish Bagchi
Atrish Bagchi is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging, Genetics, Pulmonary and Respiratory Medicine and Nuclear Energy and Engineering, having authored 7 papers that have together received 363 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (6 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Lung Cancer Treatments and Mutations (1 paper), Genetic and rare skin diseases. (1 paper), CAR-T cell therapy research (1 paper) and Genomics and Rare Diseases (1 paper). The work is most often cited by research in Oncology (115 citations), Radiology, Nuclear Medicine and Imaging (109 citations), Biomaterials (22 citations), Molecular Biology (106 citations) and Pulmonary and Respiratory Medicine (37 citations). Atrish Bagchi has collaborated with scholars based in United States, Netherlands and United Kingdom. Frequent co-authors include Kathryn M. Ferguson, Karl R. Schmitz, Rob C. Roovers, Paul M.P. van Bergen en Henegouwen, Mark A. Lemmon, Nicholas J. Bessman, Amélie Forest, Scott W. Eastman, Yang Shen and Jaafar N. Sleiman Haidar. Their work appears in journals such as Structure, Biophysical Journal, Molecular Cancer Therapeutics, Biochemical and Biophysical Research Communications and Cell Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.